Tomoya Kubota

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 250 citations

Medicine, Pharmacotherapy, Pain Management +2

Native Chemical Ligation at Asx-Cys, Glx-Cys: Chemical Synthesis and High-Resolution X-ray Structure of ShK Toxin by Racemic Protein Crystallography

Bobo Dang, Tomoya Kubota, Kalyaneswar Mandal et al. · Journal of the American Chemical Society · 2013 · 95 citations

Life Sciences, Biochemistry, Molecular Biology +13

CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation

Tomoya Kubota, C Nakajima-Taniguchi, Tsuyoshi Fukuda et al. · The Pharmacogenomics Journal · 2006 · 90 citations

Medicine, Pharmacokinetics, Pharmacology +16

Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia

Xiaofei Du, João L. Carvalho-de-Souza, Cenfu Wei et al. · Proceedings of the National Academy of Sciences · 2020 · 80 citations · Full text

Life Sciences, Neurology, Neuroscience +17